Advances in the Research of &bgr;-Ketoacyl-ACP Synthase III (FabH) Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|8|1225-1237

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.8, 2012-03, pp. : 1225-1237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bacterial &bgr;-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) as a Target for Novel Antibacterial Agents Design

By  

Current Medicinal Chemistry, Vol. 22, Iss. 5, 2015-02 ,pp. : 651-667

Bentham Science Publishers

Access to resources Recommend Favorite

Bacterial #946;-Ketoacyl-Acyl Carrier Protein Synthase III (FabH): An Attractive Target for the Design of New Broad-Spectrum Antimicrobial Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 1, 2008-01 ,pp. : 36-45

Bentham Science Publishers

Access to resources Recommend Favorite

Novel FabH inhibitors: a patent and article literature review (2000 – 2012)

By Luo Yin   Yang Yu-Shun   Fu Jie   Zhu Hai-Liang  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1325-1336

Informa Healthcare

Access to resources Recommend Favorite

The &bgr;-Ketoacyl-ACP Synthase from Mycobacterium tuberculosis as Potential Drug Targets

By  

Current Medicinal Chemistry, Vol. 18, Iss. 9, 2011-03 ,pp. : 1318-1324

Bentham Science Publishers

Access to resources Recommend Favorite

Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013)

By Song Heng   Ao Gui-Zhen   Li Huan-Qiu  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. : 19-27

Informa Healthcare

Access to resources Recommend Favorite